Literature DB >> 17146058

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.

Chun-Hyung Kim1, Maureen K Hahn, Yoosook Joung, Susan L Anderson, Angela H Steele, Michelle S Mazei-Robinson, Ian Gizer, Martin H Teicher, Bruce M Cohen, David Robertson, Irwin D Waldman, Randy D Blakely, Kwang-Soo Kim.   

Abstract

The norepinephrine transporter critically regulates both neurotransmission and homeostasis of norepinephrine in the nervous system. In this study, we report a previously uncharacterized and common A/T polymorphism at -3081 upstream of the transcription initiation site of the human norepinephrine transporter gene [solute carrier family 6, member 2 (SLC6A2)]. Using both homologous and heterologous promoter-reporter constructs, we found that the -3081(T) allele significantly decreases promoter function compared with the A allele. Interestingly, this T allele creates a new palindromic E2-box motif that interacts with Slug and Scratch, neural-expressed transcriptional repressors binding to the E2-box motif. We also found that both Slug and Scratch repress the SLC6A2 promoter activity only when it contains the T allele. Finally, we observed a significant association between the -3081(A/T) polymorphism and attention-deficit hyperactivity disorder (ADHD), suggesting that anomalous transcription factor-based repression of SLC6A2 may increase risk for the development of attention-deficit hyperactivity disorder and other neuropsychiatric diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146058      PMCID: PMC1748193          DOI: 10.1073/pnas.0510836103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  The snail superfamily of zinc-finger transcription factors.

Authors:  M Angela Nieto
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.

Authors:  M K Hahn; R D Blakely
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

3.  Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS).

Authors:  P J Ambrosini
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-01       Impact factor: 8.829

Review 4.  Neurotransmitter transporters: recent progress.

Authors:  S G Amara; M J Kuhar
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

5.  Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; John H Heiligenstein; Douglas E Faries; Nora Galil; Ralf Dittmann; Graham J Emslie; Christopher J Kratochvil; Harry F Laws; Kory J Schuh
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

6.  A proximal promoter domain containing a homeodomain-binding core motif interacts with multiple transcription factors, including HoxA5 and Phox2 proteins, and critically regulates cell type-specific transcription of the human norepinephrine transporter gene.

Authors:  Chun-Hyung Kim; Dong-Youn Hwang; Jae-Joon Park; Kwang-Soo Kim
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

7.  Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.

Authors:  Chun-Hyung Kim; Cyrus P Zabetian; Joseph F Cubells; Sonhae Cho; Italo Biaggioni; Bruce M Cohen; David Robertson; Kwang-Soo Kim
Journal:  Am J Med Genet       Date:  2002-03-01

8.  Mice lacking the norepinephrine transporter are supersensitive to psychostimulants.

Authors:  F Xu; R R Gainetdinov; W C Wetsel; S R Jones; L M Bohn; G W Miller; Y M Wang; M G Caron
Journal:  Nat Neurosci       Date:  2000-05       Impact factor: 24.884

9.  Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region.

Authors:  R E Urwin; B Bennetts; B Wilcken; B Lampropoulos; P Beumont; S Clarke; J Russell; S Tanner; K P Nunn
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population.

Authors:  Brian McEvoy; Ziarih Hawi; Michael Fitzgerald; Michael Gill
Journal:  Am J Med Genet       Date:  2002-08-08
View more
  52 in total

1.  Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.

Authors:  Heinrich J G Matthies; Jessica L Moore; Christine Saunders; Dawn Signor Matthies; Lynne A Lapierre; James R Goldenring; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 3.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis.

Authors:  Sabrina D Robertson; Heinrich J G Matthies; W Anthony Owens; Vidiya Sathananthan; Nicole S Bibus Christianson; J Phillip Kennedy; Craig W Lindsley; Lynette C Daws; Aurelio Galli
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 5.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

6.  Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini.

Authors:  Anne Vuorenpää; Trine N Jørgensen; Amy H Newman; Kenneth L Madsen; Mika Scheinin; Ulrik Gether
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

Review 7.  Genetics of human aggressive behaviour.

Authors:  Ian W Craig; Kelly E Halton
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

8.  Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Authors:  W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

9.  Rats and humans paying attention: cross-species task development for translational research.

Authors:  Elise Demeter; Martin Sarter; Cindy Lustig
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

Review 10.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.